This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2007-2008.
Company Filing History:
Years Active: 2007-2008
Title: Masako Hirota: Innovator in Pharmaceutical Chemistry
Introduction
Masako Hirota is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. His work has implications for treating various diseases and conditions.
Latest Patents
Masako Hirota holds 2 patents that focus on ORL1-receptor antagonists. His first patent involves alpha aryl or heteroaryl methyl beta piperidino propanamide compounds. This invention provides compounds that are useful in treating diseases such as pain and various CNS diseases. The compounds are characterized by specific chemical formulas that include various substituents, which enhance their therapeutic potential.
His second patent features alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds. Similar to his first patent, these compounds also exhibit ORL1-receptor antagonist activity, making them valuable in the treatment of similar medical conditions.
Career Highlights
Masako Hirota is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other talented scientists and contribute to innovative research in drug development.
Collaborations
Some of his notable coworkers include Yoshinobu Hashizume and Yukari Matsumoto. Their collaborative efforts have further advanced the research and development of new pharmaceutical compounds.
Conclusion
Masako Hirota's contributions to pharmaceutical chemistry through his innovative patents highlight the importance of research in developing new treatments for various medical conditions. His work continues to impact the field positively.